The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eat more plants for influenza resilience: Antibiotic treatment worsens influenza in mice, possibly because the concomitant loss of the microbiota interrupts the production of bioactive metabolites. Steed et al. found that a microbial product, desaminotyrosine (DAT), produced by an obligate clostridial anaerobe from the digestion of plant flavonoids, is beneficial during influenza. DAT enters the bloodstream and triggers type I interferon signaling, which then augments antiviral responses by phagocytic cells. Without DAT, influenza virus causes inflammation and severe disease. Science , this issue p. 498
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.220”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [220]
In the citing paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Cited by
Items 301–400 of 583
Renu, S., Deblais, L., Patil, V., Schrock, J., Kathayat, D., Srivastava, V., Feliciano-Ruiz, N., Han, Y., Ramesh, A., Lakshmanappa, Y. S., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02674-21 · Cited by 23
“receptors (8), and the microbial metabolites triggers type-I interferon signaling (9)”
BackgroundRaj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 17
Wang, Q., Fang, Z., Xiao, Y., Wang, H., Zhang, P., Lu, W., Zhang, H., & Zhou, X. (2023) · Nutrients · doi:10.3390/nu15163659 · Cited by 17
“found that lung phagocytes and bone-marrow-derived macrophages (BMDMs) in DAT treatment are essential mediators of type I IFN-mediated protection from influenza virus infection [13].”
BackgroundMethodInfluentialHan, M., Lu, Q., Wang, D., Zhou, K., Jia, C., Teng, L., Hamuti, A., Peng, X., Hu, Y., Li, W., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00950-24 · Cited by 19
“Desaminotyrosine, a microbial metabolite produced by Clostridium orbiscindens , was discovered to protect against influenza by augmenting type I interferon signaling in a mouse model (21).”
Immune crosstalk between respiratory and intestinal mucosal tissues in respiratory infections
Zhao, M., Zhou, L., & Wang, S. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.12.013 · Cited by 18
Chemoproteomic Analysis of Microbiota Metabolite–Protein Targets and Mechanisms
Zhao, X., Yang, X., & Hang, H. C. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00758 · Cited by 16
Association of sirtuins (SIRT1-7) with lung and intestinal diseases
Chen, Y., Zhou, D., Feng, Y., Li, B., Cui, Y., Chen, G., & Li, N. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04462-9 · Cited by 16
“Recent studies have shown that desaminotyrosine (DAT), as one of the metabolites of intestinal microflora, can protect from influenza through diminutions of lung immunopathology [10].”
Gao, Y., Liang, Z., Lv, N., Shan, J., Zhou, H., Zhang, J., & Shi, L. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03509-0 · Cited by 15
“Since DAT is a quercetin degradation product by gut microbiota [27], we observed the anti-viral and antiinflammatory effects of DAT in MH-S cells.”
BackgroundMethodInfluentialRole of the gut microbiota in airway immunity and host defense against respiratory infections
Willers, M., & Viemann, D. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0281 · Cited by 16
Wang, P., Shang, R., Ma, Y., Wang, D., Zhao, W., Chen, F., Hu, X., & Zhao, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2106180 · Cited by 16
“Similarly, Ashley et al. showed that 3-hydroxyphenylpropionic acid protected against influenza by increasing type I IFN signaling and decreasing lung immunopathology in a mouse model (Steed et al. 2017).”
BackgroundHerbal medicine in the treatment of COVID-19 based on the gut–lung axis
He, Q., Shi, Y., Tang, Q., Xing, H., Zhang, H., Wang, M., & Chen, X. (2022) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000038 · Cited by 16
“In addition, the microbial metabolite desaminotyrosine (DAT) protects mice from influenza virus infection by enhancing type I interferon (IFN) signal transduction[54].”
BackgroundOn, J.-Y., Kim, S., Kim, J.-M., Park, S., Kim, K. H., Lee, C.-H., & Kim, S. (2023) · Nutrients · doi:10.3390/nu15092022 · Cited by 15
“recently attracted attention as physiological activities, such as protecting the host from influenza infection by regulating the immune balance, that have been reported [57,58].”
BackgroundGastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19
Yang, Y. K., Huang, W., Fan, Y., & Chen, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.647508 · Cited by 16
“It was found that DAT had protective effects against respiratory viral infection at the early stage, through priming the pulmonary type I IFN responses, while it could lead to a worse outcome at the later stage (Steed et al., 2017).”
BackgroundInfluentialA Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial Infection
Park, Y. J., Kang, B. H., Kim, H.-J., Oh, J. E., & Lee, H. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.799598 · Cited by 15
“Recently, the gut microbiota was found to influence type I IFN signaling at the remote tissues such as the lung, lymph nodes, and spleen (4, 5).”
BackgroundZhou, J., Han, J., Wei, Y., & Wang, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400638r · Cited by 13
“15 To test whether the increased reduced GSH pool was responsible for DAT's dual effect on suppression of Il-6 while augmentation of ISGs upon LPS simulation, we pretreated WT BMDMs with buthionine sulfoximine (BSO), 31 a non-electrophilic inhibitor of GSH synthesis, 12 h before LPS stimulation…”
García-Mauriño, C., Shao, Y., Miltz, A. R., Lawley, T. D., Rodger, A., & Field, N. M. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101072 · Cited by 15
“Participantcharacteristicsvaried(includingratesofvLRTI hospital admission) by fi rst-week stool sample availability (1082 in the study population vs 2223 BBS participants without fi rst-week stool sample; appendix pp 6 – 9).”
The influence of early-life microbial exposures on long-term respiratory health
Taylor, S., Simpson, J. L., & Rogers, G. B. (2021) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2021.05.003 · Cited by 18
Liu, M., Liu, T., Wang, X., Yu, C., Qin, T., Li, J., Zhang, M., Li, Z., Cui, X., Xu, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.947112 · Cited by 15
Gierse, L. C., Meene, A., Skorka, S. B., Cuypers, F., Surabhi, S., Ferrero‐Bordera, B., Kreikemeyer, B., Becher, D., Hammerschmidt, S., Siemens, N., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03447-22 · Cited by 19
Flavonoid Synthesis by Deinococcus sp. 43 Isolated from the Ginkgo Rhizosphere
Zhou, J., Zou, K., Fu, S., Duan, Z., Zhang, G., Wu, X., Huang, J., Li, S., Liu, X., Zhang, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11071848 · Cited by 13
Role of the intestinal microbiota in host defense against respiratory viral infections
Boncheva, I., Poudrier, J., & Falcone, E. L. (2024) · Current Opinion in Virology · doi:10.1016/j.coviro.2024.101410 · Cited by 13
Influenza and the gut microbiota: A hidden therapeutic link
Luo, C., Yang, Y., Jiang, C., Lv, A., Zuo, W., Ye, Y., & Ke, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37661 · Cited by 14
“In the case of viral respiratory infections caused by influenza viruses, treatment with antibiotics can also have an impact on the gut microbiota, thereby weakening the host ’ s innate and adaptive defenses [26 – 29].”
BackgroundFadaee, M., Mahrooghi, D., Lahouty, M., Oskouie, S. A., & Nezhadi, J. (2025) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2025.105837 · Cited by 14
Zama, D., Totaro, C., Biscardi, L., Rocca, A., Turroni, S., Brigidi, P., & Lanari, M. (2022) · Nutrients · doi:10.3390/nu14142992 · Cited by 14
“, 2017, [15] Evaluation of DAT in protecting from influenza through type I IFN.”
BackgroundWang, J., Huang, M., Du, Y., Chen, H., Li, Z., Zhai, T., Ou, Z., Huang, Y., Bu, F., Zhen, H., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10137-8 · Cited by 13
“The commensal microbiota passively colonise and exert antiviral effects by modulating the maturation of immune cells and inducing the release of immune factors [24–26].”
Kato, T., Kamiya, S., Narasaki, S., Sumii, A., Tsutsumi, Y. M., Machida, K., Hara, K., Izumi-Mishima, Y., Tsutsumi, R., & Sakaue, H. (2023) · Nutrients · doi:10.3390/nu15194252 · Cited by 13
“Administration of PHGG is known to be increased by intestinal clostridium bacteria [24], and DAT (desaminotyrosine), a metabolite from clostridium orbiscindens, increases resistance to infection by the influenza virus via IFN-I signal [34].”
BackgroundMa, L., Ji, L., Wang, T., Zhai, Z., Su, P., Zhang, Y., Wang, Y., Zhao, W., Wu, Z., Yu, H., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02228-3 · Cited by 14
Cribas, E. S., Denny, J. E., Maslanka, J. R., & Abt, M. C. (2021) · Infection and Immunity · doi:10.1128/iai.00730-20 · Cited by 13
The respiratory tract microbiome: moving from correlation to causation
Morton, R., & Singanayagam, A. (2022) · European Respiratory Journal · doi:10.1183/13993003.03079-2021 · Cited by 13
An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota
Li, S., Zhou, Y., Yan, D., & Wan, Y. (2022) · Viruses · doi:10.3390/v14081774 · Cited by 14
“Microbial metabolites such as deaminated tyrosine (DAT, derived from flavonoid and amino acid metabolism) and short-chain fatty acids (SCFAs, the end products of dietary fiber fermentation by commensal bacteria) have been shown to be critical in regulating the anti-virial immunities in the respiratory tract [12,13].”
BackgroundEmerging nanotherapeutic strategies targeting gut-X axis against diseases
Sun, A., Liu, H., Sun, M., Yang, W., Liu, J., Lin, Y., Shi, X., Sun, J. Y., & Liu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115577 · Cited by 14
Chen, Y., Song, L., Chen, M., Huang, Y., Wang, Z., Ren, Z., & Xu, J. (2024) · Nutrients · doi:10.3390/nu16121923 · Cited by 13
“Desaminotyrosine (DAT) is a gut microbiota-associated degradation product of flavonoids or amino acid metabolism that protects against influenza infection by upregulating type I IFN signaling [20].”
BackgroundA host-centric view of the microbiota metabolome
Yamada, T., & Palm, N. W. (2025) · Immunity · doi:10.1016/j.immuni.2025.11.006 · Cited by 15
Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
Dvořák, Z., Klapholz, M., Burris, T. P., Willing, B. P., Gioiello, A., Pellicciari, R., Galli, F., March, J. C., O’Keefe, S. J., Sartor, R. B., et al. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000035 · Cited by 12
“Recent data suggest that DAT protects against influenza virus infection by inducing type I interferons (Steed et al., 2017).”
BackgroundGut–Lung Microbiota Interaction in COPD Patients: A Literature Review
Krūmiņa, A., Bogdanova, M., Gintere, S., & Vīksna, L. (2022) · Medicina · doi:10.3390/medicina58121760 · Cited by 14
“lung stroma provide homeostasis of interferon activity in the pulmonary tract and prevent the development of viral respiratory infections like influenza by early control of virus replication [83,84].”
BackgroundLeveraging the microbiome in the treatment of sepsis: potential pitfalls and new perspectives
Biemond, J. J., McDonald, B., & Haak, B. W. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001019 · Cited by 13
Influenza A virus and its antiviral drug treatment options
Singh, P. P., Sodhi, K. K., Bali, A. K., & Shree, P. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100083 · Cited by 12
Chen, H., Li, S., Pan, B., Liu, K., Yu, H., Ma, C., Qi, H., Zhang, Y., Huang, X., Ouyang, D., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1194401 · Cited by 13
“In addition, intestinal flora produces some dispersal and specific metabolites that enter the systemic circulation and have distal effects including on the lung (Steed et al., 2017).”
BackgroundShaik, S. M., Cao, Y., Gogola, J. V., Dodiya, H. B., Zhang, X., Boutej, H., Han, W., Križ, J., & Sisodia, S. S. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00668-7 · Cited by 13
“Interestingly, desaminotyrosine (DAT), a metabolite produced by a subset of intestinal microbes was shown to enhance antiviral IFN responses in mice [97] and Indole-3-lactic acid (ILA), a tryptophan metabolite associated with commensal Bifidobacterium bacteria that decreases intestinal inflammation…”
BackgroundAromatic amino acid metabolites alter interferon signaling and influenza pathogenesis
Anand, G., Clark-Dinovo, C., Perry, A. M., Goodwin, V. M., Raymond, E. S., Sakleshpur, S., & Steed, A. L. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1232573 · Cited by 15
Self-citationKullberg, R. F. J., Hugenholtz, F., Brands, X., Kinsella, C. M., Sengers, H. P., Butler, J. M., Deijs, M., Klein, M., Faber, D. R., Scicluna, B. P., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101074 · Cited by 12
Saejung, C., Lomthaisong, K., & Kotthale, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13828 · Cited by 12
“According to previous study, this metabolite can protect against influenza virus [65] and maintain systematic immune homeostasis [66].”
COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome
Venzon, M., & Cadwell, K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.11.017 · Cited by 14
The effect of partially hydrolyzed guar gum on preventing influenza infection
Takahashi, C., & Kozawa, M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.030 · Cited by 11
High-fat diet impairs microbial metabolite production and aggravates influenza A infection
Hornung, F., Sureshkumar, H. K., Klement, L., Reisser, Y., Wernike, C., Nischang, V., Jordan, P. M., Werz, O., Hoffmann, C., Löffler, B., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02367-w · Cited by 12
“Furthermore, microbial metabolites are considered to exhibit antiviral efficacy through their interaction with the interferon response [9, 10].”
Pamungkas, K. M. N., Dewi, P. I. S. L., Alamsyah, A. Z., Dewi, N. L. P. Y., Dewi, N. N. G. K., Mariadi, I. K., & Sindhughosa, D. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106810 · Cited by 11
Xie, M., Li, Y., Olsen, R. E., Ringø, E., Yang, Y., Zhang, Z., Ran, C., & Zhou, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968348 · Cited by 11
Ying, H., Xie, W., Wang, M., He, J., Zhang, H., & Yu, C.-H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.969526 · Cited by 17
“More notably, degraded by Clostridium orbiscindens, diet flavonoids were cracked and converted into desaminotyrosine, which can up-regulate the signal pathway of type I interferon and enhance the host antiviral immune response (Steed et al., 2017).”
BackgroundAlpha‐ketoglutaric acid based polymeric particles for cutaneous wound healing
Jaggarapu, M. M. C. S., Ghosh, D., Johnston, T. M., Yaron, J. R., Mangal, J. L., Inamdar, S., Gosangi, M., Rege, K., & Acharya, A. P. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37539 · Cited by 11
Molecular basis of phytochemical–gut microbiota interactions
Lal, S., Akhtar, M. S., Khan, M. F., Aldosari, S. A., Mukherjee, M., & Sharma, A. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103824 · Cited by 11
Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
Flores-Torres, A. S., & Samarasinghe, A. E. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.852067 · Cited by 14
“Microbe-associated metabolites, like desaminotyrosine and acetate, enhance antiviral responses against IAV and RSV in mice through an upregulation of IFN signaling (267, 268).”
BackgroundOgimi, C., Krantz, E. M., Golob, J. L., Liu, C., Waghmare, A., Akramoff, A., Mallory, A., Leisenring, W. M., Jerome, K. R., Chow, V. A., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01790-8 · Cited by 11
Gautier, T., Oliviero, N., Ferron, S., Pogam, P. L., Gall‐David, S. L., Sauvager, A., Leroyer, P., Cannie, I., Dion, S., Sweidan, A., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1023315 · Cited by 12
“Desaminotyrosine, produced by Clostridium orbiscidens, can protect against influenza virus infection by increasing the expression of IFN-I way (Steed et al., 2017; Wei et al., 2020).”
BackgroundWu, C., Zhou, J., Long, F., Zhang, W., Shen, H., Zhu, H., Xu, J., & Li, S. (2020) · Food & Function · doi:10.1039/d0fo02434a · Cited by 11
Balmant, B. D., Torrinhas, R. S., da Rocha, I. M. G., Fonseca, D. C., Formiga, F. F. C., Bonfá, E., Borba, E. F., & Waitzberg, D. L. (2020) · Nutrition · doi:10.1016/j.nut.2020.111115 · Cited by 13
“Importantly, a healthy gut microbiota profile can contribute to protecting the host against respiratory infections [8,9], whereas an unbalanced gut microbiota profile (dysbiosis) is associated with several infectious diseases and chronic inflammation [10,11].”
Du, H., Liu, X., Shen, J., Yuan, H., Zhang, H., Xi, G., Li, Y., Wang, Y., Zhang, J., Yang, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202417827 · Cited by 13
The dynamics of microbiome and virome in migratory birds of southwest China
Luo, Q., Gao, H., Xiang, Y., Li, J., Lin, D., Wang, X., Liu, F., Guo, Y., Shen, C., Ding, Q. W., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00703-z · Cited by 13
Lobel, L., & Garrett, W. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.002 · Cited by 10
“To examine the host immune mechanisms related to DAT-induced protection, Steed et al. (2017) asked whether the adaptive immune response was involved by examining Rag1 / mice.”
BackgroundMethodInfluentialZhang, H., Ma, W., Sun, Z., Zhu, C., Werid, G. M., Ibrahim, Y. M., Zhang, W., Pan, Y., Shi, D., Chen, H., et al. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109134 · Cited by 11
Yu, X., Cai, T., Fan, L., Liang, Z., Du, Q., Wang, Q., Yang, Z., Vlahos, R., Wu, L., & Lin, L. (2021) · Clinical Science · doi:10.1042/cs20210050 · Cited by 10
Guo, J., & Liyang, Y. A. N. G. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2023-100 · Cited by 11
“For example, Clostridium sporogenes can decompose flavonoids into desaminotyrosine, and the addition of desaminotyrosine enhances type I interferon immune signaling conduction and activates phagocytosis by macrophages to suppress influenza virus infection [ 37 ].”
BackgroundEffect of Mixed Probiotics on Alleviating H1N1 Influenza Infection and Regulating Gut Microbiota
Wang, H., Zhao, Y., Pei, Z., Zhao, J., Zhang, P., Zhang, X., Zhang, Z., & Lu, W. (2024) · Foods · doi:10.3390/foods13193079 · Cited by 12
“Although the influenza virus is primarily transmitted through the respiratory tract, the gut microbiota can also significantly influence the course of influenza infection [28].”
BackgroundZhu, P., Savova, M. V., Kindt, A. S. D., the PRESTO study team, Wopereis, H., Belzer, C., Harms, A. C., & Hankemeier, T. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400583 · Cited by 12
They are what you eat: Shaping of viral populations through nutrition and consequences for virulence
Honce, R., & Schultz‐Cherry, S. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008711 · Cited by 10
Advances in aggregation induced emission (AIE) materials in biosensing and imaging of bacteria
Maruthi, M., & Kalangi, S. K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.06.015 · Cited by 10
“, Vitamin K) and contribute to the overall immunity in adults.(1) Contrarily, bacteria remain a major cause of fatal infectious diseases globally.”
BackgroundCOVID-19 Spotlights Connections between Disease and Multiple Lifestyle Factors
Enichen, E. J., Harvey, C., & Demmig‐Adams, B. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221123005 · Cited by 12
COVID-19 and the Microbiome: The Gut-Lung Connection
Aan, F. J., Glibetić, N., Montoya‐Uribe, V., & Matter, M. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00048-6 · Cited by 13
“Clostridium orbiscindens, a gut commensal, may enhance type I IFN signaling to promote immune protection against influenza infection (Steed et al., 2017).”
Zhang, H., Wei, H., Qin, X., Song, H., Yang, M., Zhang, L., Liu, Y., Wang, Z., Zhang, Y., Lai, Y., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.164 · Cited by 9
Zhang, F., Luan, J., Suo, L., Wang, H., Zhao, Y., Sun, T., Ni, Y., Cao, H., Zou, X., & Liu, B. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02639-24 · Cited by 12
“Studies in mice demonstrated that microbial metabolite desaminotyrosine can enhance type I IFN signaling against influenza (16).”
Miquelianin inhibits IAV infection via the MAPK signaling pathway both in vitro and in vivo
Li, H., Shen, B., Bi, Y., Sun, Y., Zhang, S., Xue, K., Wang, Q., Qian, B., Zhang, J., Fan, L., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532336 · Cited by 9
He, S., Lu, S., Yang, T., Ma, H., He, Y., Mi, J., Yue, K., Huang, Y., Song, L., Xiao, Y., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02384-9 · Cited by 11
“Clostridium prevents influenza by degrading flavonoids into desaminotyrosine (DAT), a metabolite that boosts type 1 interferon (IFN-I) signaling [10].”
Li, F., Wang, L., Cai, Y., Luo, Y., & Shi, X. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115464 · Cited by 10
Tong, J., Ma, W., Yang, R. Y., Wang, T., Chen, X., Zhang, X., Tang, X., Wen, Y., Chang, J., & Chen, D. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108884 · Cited by 9
Inhibition of Hepatitis E Virus Replication by Novel Inhibitor Targeting Methyltransferase
Hooda, P., Chaudhary, M., Parvez, M. K., Sinha, N., & Sehgal, D. (2022) · Viruses · doi:10.3390/v14081778 · Cited by 9
“The most promising HEV-MTase inhibitor (HPPA) identified through virtual screening is a flavonoid metabolite of Clostridium orbiscindens, which is present in some human guts and prevents Influenza virus propagation [53].”
BackgroundLi, S., Zhang, H., Xiao, J., Yuan, T., Shu, Z., Min, Y., Xu, W., Yin, Y., & Zhang, X. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00358 · Cited by 8
“…been investigated in previous studies (Ubeda et al., 2013; van Nood et al., 2013; Singh et al., 2014; Buffie et al., 2015; Caballero et al., 2015; Stripling et al., 2015; Lewis and Pamer, 2017; Deng et al., 2019), while less attention has been given to the respiratory microorganisms, especially…”
BackgroundRaudenská, M., Bugajová, M., Kalfeřt, D., Plzák, J., Šubrt, A., Tesařová, P., & Masařík, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189216 · Cited by 9
Interplay between bacteria and pulmonary immune system in respiratory infections
Li, J., Yang, L., Qin, X., Zhao, M., & Wang, S. (2026) · hLife · doi:10.1016/j.hlife.2025.09.006 · Cited by 8
“[132,100].”
Finnegan, D., Mechoud, M. A., Connolly, C., FitzGerald, J. A., Beresford, T. P. J., Mathur, H., Brennan, L., Cotter, P. D., & Loscher, C. E. (2024) · Foods · doi:10.3390/foods13152392 · Cited by 10
Plant Polyphenols: The Futuristic Bioactive Therapeutics for Skin Care
Singh, B., Mal, G., Sharma, D., Gautam, S. K., Kumar, M., Solimene, U., Metalla, M., & Marotta, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813008-7.00030-8 · Cited by 10
Dong, L., Zhao, C. G., Zhang, F., Ma, Y., Song, C., Penttinen, P., Zhang, S., & Li, Z. (2022) · LWT · doi:10.1016/j.lwt.2022.114169 · Cited by 8
Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
Angelis, M. D., Scagnolari, C., Oliva, A., Cavallari, E. N., Celani, L., Santinelli, L., Innocenti, G. P., Borrazzo, C., Ceccarelli, G., Vullo, V., et al. (2019) · Microorganisms · doi:10.3390/microorganisms7060162 · Cited by 8
“albicans in humans and that components of the gut microbiota can have distal effects on responses to a number of infections through the modulation of type I IFN [10,11].”
BackgroundInfection Heterogeneity and Microbiota Differences in Chicks Infected by Salmonella enteritidis
Wu, S., Cong, G., Zhang, Q., Yao, H., Wang, Z., Kang, K., He, X., & Shi, S. (2021) · Microorganisms · doi:10.3390/microorganisms9081705 · Cited by 9
“Host susceptibility to pathogen infection is frequently heterogeneous [7], as demonstrated by the phenomenon of the median lethal dose (lethal dose 50 [LD50]), which describes the microbe dose that will kill only 50% of a test population [8].”
BackgroundTargeting microbiome, drug metabolism, and drug delivery in oncology
Sumiyoshi, A., Fujii, H., & Okuma, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114902 · Cited by 9
Chuong, J. J. H., Livstone, E. M., & Barwick, K. W. (1982) · PubMed · Cited by 8
Fortman, D. P. E. D. G., Kullberg, R. F. J., Wiersinga, W. J., & Haak, B. W. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.02.016 · Cited by 8
Diet–microbiome synergy underlies obesity-associated immunotherapy efficacy
Desharnais, L., Swaby, A. M., Messaoudene, M., Doré, S., Yu, M. W., Fiset, B., Breton, V., Ponce, M., Hu, Y., Wilson, L., et al. (2026) · Nature · doi:10.1038/s41586-026-10750-x · Cited by 9
“DAT is a microbiota-derived phenylpropionate produced during tyrosine metabolism, previously described to have immunomodulatory properties, including the ability to influence host antiviral and anti-tumour immunity 49–51 .”
Santa, K. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221017151705 · Cited by 7
Wang, W. J., Zhu, S., Zhang, Y., Chu, L., Liu, S., Yang, H., & Wu, H. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100374 · Cited by 7
Potential use of serum‐derived bovine immunoglobulin/protein isolate for the management of COVID ‐19
Utay, N. S., Asmuth, D. M., Gharakhanian, S., Contreras, M., Warner, C. D., & Detzel, C. J. (2021) · Drug Development Research · doi:10.1002/ddr.21841 · Cited by 10
“The spike protein from these two viruses have 76% homology; a similar level of homology exists between bovine coronavirus and SARS-CoV-2 spike protein epitopes, 70 – 80% (Tilocca et al., 2020), which is likely due to the closely related evolution of group 2 coronaviruses (Vijgen et al., 2006).”
BackgroundLiong, S., Miles, M. A., Mohsenipour, M., Liong, F., Hill‐Yardin, E. L., & Selemidis, S. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00062.2023 · Cited by 7
Vu, V. T. D., Mahmood, R., Armstrong, H., & Santer, D. M. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad044 · Cited by 8
“93,94 Clostridium butyricum ω -3 fatty acid 18-HEPE production led to upregulated IFN-λ levels in the lung.”
BackgroundLu, J., Li, J., Yin, J.-T., Li, C., Zhang, S., Guo, J., & Duan, J. (2021) · Future Foods · doi:10.1016/j.fufo.2021.100069 · Cited by 7
Long-term effects on liver metabolism induced by ceftriaxone sodium pretreatment
Lai, C., Chen, L., Zhong, X., Tang, Z., Zhang, B., Luo, Y. H., Li, C., Jin, M., Chen, X., Li, J., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122238 · Cited by 9
Gut‑lung axis microbiome: Towards precision medicine in respiratory disorders (Review)
Manoharan, S., Oviya, I. R., Prabahar, A., Bhasuran, B., & Raja, K. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.376 · Cited by 7
Mao, Z., Liu, C., Ni, J., Huang, M., Qu, W., Chen, W., Shen, Y., Qin, T., Gao, M., Zheng, S., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.08.004 · Cited by 6
Yuan, S., Bremmer, A., Yang, X., & Hu, Q. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.11.023 · Cited by 8
Cui, X., Liu, X., Wang, F., Lou, K., Hong, J., Bai, H., Chen, R., Yang, Y., & Liu, Q. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03858-4 · Cited by 6
Avian influenza and gut microbiome in poultry and humans: A “One Health” perspective
Zhang, L., Zhou, E., Liu, C., Tian, X., Xue, B., Zhang, K., & Luo, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.10.016 · Cited by 7
“On the other hand, the gut microbiome can indirectly suppress AIV infection by initiating IFN-I responses to drive host antiviral immunity, inducing apoptosis of infected cells, and promoting the elimination of AIV [38 , 44] .”
BackgroundYan, Q., Xing, J.-H., Zou, R., Sun, M., Zou, B., Wang, Y., Niu, T., Yu, T., Huang, H., Yang, W., et al. (2024) · Veterinary Research · doi:10.1186/s13567-024-01391-x · Cited by 6
“Steed et al. demonstrated that the inclusion of desamino-tyrosine (DAT, a flavonoid degradation derivative of intestinal bacteria) in drinking water shielded mice from the repercussions of influenza virus infections, particularly mortality and weight reductions [76].”
BackgroundKaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent
Du, R., Sun, J., Zhang, C., Chen, C., Chen, Z., Anirudhan, V., Cui, Q., Wáng, H., Rong, L., & Ning, Y. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106141 · Cited by 7
Metadata
- Authors
- Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., Boon, A. C. M., Lenschow, D. J., & Stappenbeck, T. S.
- Affiliations
- Washington University in St. Louis (US)
- ITMO University (RU)
- Corresponding author
- Stappenbeck, Thaddeus S.
- ORCID
- Venue
- Science
- Published
- 2017-08-04
- Volume
- 357
- Issue
- 6350
- Pages
- 498-502
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5753406
- OpenAlex
- W2743370588
- Cited by
- 569
- References
- 55
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 68 · 2023: 74 · 2022: 80 · 2021: 94 · 2020: 78 · 2019: 37 · 2018: 29 · 2017: 8
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Crohn’s Colitis (award312855)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Keywords
- influenza, type I interferon, gut microbiota, microbial metabolites, plant flavonoids, Clostridium, antibiotic-induced dysbiosis, antiviral immunity, phagocytes, inflammation, plant-based diet
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Line, Clostridium perfringens, Interferon Type I, Lung, Orthomyxoviridae Infections, Phenylpropionates, Signal Transduction, Mice, Knockout, GTP-Binding Proteins, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.